Jade Biosciences, Inc. - JBIO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$748.2M
QoQ value delta ($000)
+$20.53M (+2.82%)
Implied price effect (QoQ)
-6.77%
Shares
Total shares
52,023,529
QoQ shares delta
+4,852,653 (+10.29%)
Total shares held by funds (by quarter)

Market chart (JBIO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 122 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 99,550 7,085,423 0.01%
Fairmount Funds Management LLC 63,976 4,553,494 4.62%
RA CAPITAL MANAGEMENT, L.P. 51,578 3,671,083 0.55%
Bellevue Group AG 49,196 3,501,502 1.17%
Venrock Adviser, LLC 45,246 3,220,364 1.69%
JANUS HENDERSON GROUP PLC 43,557 3,105,669 0.02%
Avidity Partners Management LP 34,177 1,400,708 7.73%
BlackRock, Inc. 32,510 2,313,949 0.0%
VANGUARD GROUP INC 32,337 2,095,767 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 25,242 1,796,652 0.0%
BAKER BROS. ADVISORS LP 23,057 1,641,137 0.13%
Remedium Capital Partners, LLC 22,167 1,577,750 7.88%
Versant Venture Management, LLC 21,437 1,525,820 15.16%
Samsara BioCapital, LLC 13,611 968,798 1.32%
GREAT POINT PARTNERS LLC 13,550 964,462 3.11%
MARSHALL WACE, LLP 13,274 944,776 0.01%
Aberdeen Group plc 12,185 867,284 0.02%
GEODE CAPITAL MANAGEMENT, LLC 11,559 822,520 0.0%
Soleus Capital Management, L.P. 11,194 796,744 0.45%
ACORN CAPITAL ADVISORS, LLC 11,053 786,760 3.14%
STATE STREET CORP 9,212 655,690 0.0%
Affinity Asset Advisors, LLC 8,991 639,956 0.46%
DRIEHAUS CAPITAL MANAGEMENT LLC 8,928 635,498 0.07%
RTW INVESTMENTS, LP 8,053 573,205 0.08%
Ikarian Capital, LLC 7,198 512,349 0.58%